Visual perfusion-diffusion mismatch is equivalent to quantitative mismatch

Stroke

Volumn 42, Issue 4, 2011, Pages 1010-1014

  Luby, Marie ^a,d   Ku, Katherine D ^a   Latour, Lawrence L ^a   Merino, José G ^a,b   Hsia, Amie W ^a,c   Lynch, John K ^a   Warach, Steven ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b SUBURBAN HOSPITAL   (United States)

^c WASHINGTON HOSPITAL CENTER   (United States)

^d MSC 1063   (United States)

Author keywords

acute ischemic stroke; diffusion weighted imaging; magnetic resonance imaging; mismatch; perfusion weighted imaging

Indexed keywords

ALTEPLASE;

AGE; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; FEMALE; GENDER; HUMAN; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PERFUSION WEIGHTED IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUALITATIVE MISMATCH SELECTION; QUANTITATIVE ANALYSIS; QUANTITATIVE MISMATCH SELECTION; RANKIN SCALE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

AGED; BRAIN ISCHEMIA; BRAIN MAPPING; CEREBROVASCULAR CIRCULATION; DIFFUSION MAGNETIC RESONANCE IMAGING; EVALUATION STUDIES AS TOPIC; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY;

EID: 79954875930     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.603290     Document Type: Article

References (14)

1. Warach S. New imaging strategies for patient selection for thrombolytic and neuroprotective therapies. Neurology. 2001;57:S48-S52. (Pubitemid 32831463)
2. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, Fischer M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S; DIAS Study Group. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke. 2005;36:66-73. (Pubitemid 40054177)
3. Furlan AJ, Eyding D, Albers GW, Al-Rawi Y, Lees KR, Rowley HA, Sachara C, Soehngen M, Warach S, Hacke W. Dose Escalation of Desmoteplase for Acute ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke. 2006;37: 1227-1231. (Pubitemid 43731867)
4. Hacke W, Furlan AJ, Al-Rawi Y, Davalos A, Fiebach JB, Gruber F, Kaste M, Lipka LJ, Pedraza S, Ringleb PA, Rowley HA, Schneider D, Schwamm LH, Leal JS, Soehngen M, Teal PA, Wilhelm-Ogunbiyi K, Wintermark M, Warach S. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, doubleblind, placebo-controlled study. Lancet Neurol. 2009;8:141-150.
5. Butcher KS, Parsons M, MacGregor L, Barber PA, Chalk J, Bladin C, Levi C, Kimber T, Schultz D, Funk J, Tress B, Donnan G, Davis S; EPITHET Investigators. Refining the perfusion-diffusion mismatch hypothesis. Stroke. 2005;36:1153-1159. (Pubitemid 40798731)
6. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, Bammer R, Kakuda W, Lansberg MG, Shuaib A, Coplin W, Hamilton S, Moseley M, Marks MP; DEFUSE Investigators. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) study. Ann Neurol. 2006;60:508-517. (Pubitemid 44871793)
7. Hakim AM. Ischemic penumbra: the therapeutic window. Neurology. 1998;51:S44-S46. (Pubitemid 28429324)
8. Jacobs MA, Knight RA, Soltanian-Zadeh H, Zheng ZG, Goussev AV, Peck DJ, Windham JP, Chopp M. Unsupervised segmentation of multiparameter MRI in experimental cerebral ischemia with comparison to T2, diffusion, and ADC MRI parameters and histopathological validation. J Magn Reson Imaging. 2000;11:425-437. (Pubitemid 30185883)
9. Wu O, Koroshetz WJ, Ostergaard L, Buonanno FS, Copen WA, Gonzalez RG, Rordorf G, Rosen BR, Schwamm LH, Weisskoff RM, Sorensen AG. Predicting tissue outcome in acute human cerebral ischemia using combined diffusion-and perfusion-weighted MR imaging. Stroke. 2001; 32:933-942. (Pubitemid 32285163)
10. Grandin CB, Duprez TP, Smith AM, Mataigne F, Peeters A, Oppenheim C, Cosnard G. Usefulness of magnetic resonance-derived quantitative measurements of cerebral blood flow and volume in prediction of infarct growth in hyperacute stroke. Stroke. 2001;32:1147-1153. (Pubitemid 32825799)
11. Shen Q, Meng X, Fisher M, Sotak CH, Duong TQ. Pixel-by-pixel spatiotemporal progression of focal ischemia derived using quantitative perfusion and diffusion imaging. J Cereb Blood Flow Metab. 2003;23: 1479-1488. (Pubitemid 38018267)
12. Schellinger PD, Jansen O, Fiebach JB, Pohlers O, Ryssel H, Heiland S, Steiner T, Hacke W, Sartor K. Feasibility and practicality of MR imaging of stroke in the management of hyperacute cerebral ischemia. AJNR Am J Neuroradiol. 2000;21:1184-1189. (Pubitemid 30655650)
13. Luby M, Bykowski JL, Schellinger PD, Merino JG, Warach S. Intra-and interrater reliability of ischemic lesion volume measurements on diffusion-weighted, mean transit time and fluid-attenuated inversion recovery MRI. Stroke. 2006;37:2951-2956. (Pubitemid 44900815)
14. Luby M, Warach S. Reliability of MR perfusion-weighted and diffusionweighted imaging mismatch measurement methods. AJNR Am J Neuroradiol. 2007;28:1674-1678. (Pubitemid 47598138)